Marpai, Inc. (MRAI) Marpai, Inc. operates as a technology-driven healthcare payer, concentrating its efforts on the self-insured employer market within the United States and Israel. The firm provides a comprehensive suite of supplementary services, which includes managing patient care and individual cases, actuarial evaluations, administering health savings accounts, and implementing cost-saving measures. Additionally, Marpai innovates in artificial intelligence and healthcare technology. These advanced platforms process data to anticipate and preempt issues such as diagnostic inaccuracies, preventable hospitalizations, and administrative inefficiencies. Incorporated in 2021, the company's main office is situated in New York, New York.
Sector: Services-Misc Health & Allied Services, NEC
Industry: Medical - Healthcare Plans
Marpai, Inc. OTC:MRAI Healthcare · Medical - Healthcare Plans
Mkt Cap $36.34M
EV -
SI 0.4%
Net Cash/Sh -
CLOSED · Nov 17 -21.51%$1.35 CLOSED · Nov 17 Prev close $1.72 -21.51%Close $1.35 VOL 123K $ Vol $171K RVOL 4.28x
Mkt Cap $36.34M
EV -
VOL 123K sh
$ Vol $171K
RVOL 4.28×
SI 0.4%
Net Cash/Sh -
Press Release
Marpai Reports Third Quarter 2026 Financial Results
Marpai reported Q3 2026 revenue of $4.4 million, up 9.6% year-over-year — its first YoY and sequential revenue growth since 2023. Operating loss narrowed to $2.5 million from $2.8 million, and net loss per share improved to $(0.13) from $(0.20), though cost of revenue rose 14.7% on a network-access vendor minimum payment. Nine-month revenue was $13.0 million, down 7.6% from $14.1 million due to earlier customer turnover, and net cash used in operations was $11.6 million.
• 5d ago AI analysis › Press Release
Opyn AI agents cut Marpai's provider call center costs by 40%
Opyn's AI agent suite now answers 100% of Marpai's inbound provider calls and fully resolves 70% without human assistance. Marpai reports a 40% reduction in provider call center costs since deployment, with capacity scaled without added headcount in a HIPAA-compliant 24/7 environment.
• 19d ago AI analysis › Press Release
Marpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer Clients
Marpai expanded its relationship with Claritev to incorporate pre- and post-payment integrity capabilities across the claims lifecycle. Building on the existing PHCS Network access, the deal adds solutions like Advanced Code Editing and Itemized Bill Review to detect billing errors and waste.
• 3mo ago AI analysis › Press Release
Marpai Reports Second Quarter 2026 Financial Results
Marpai reported Q2 2026 revenue of $4.2 million, a 10.5% decrease from the prior year, but achieved a 33.6% improvement in gross profit driven by lower claims processing costs. Gross margin expanded by 7.9 percentage points to 23.9%, while total operating costs and expenses decreased by 8% to $7.6 million, resulting in a slightly narrowed operating loss of $3.4 million.
• 3mo ago AI analysis › Press Release
Marpai Announces $12 Million Private Placement led by Mitchell Companies
Marpai announced a $12 million private placement of convertible preferred stock led by Mitchell Companies to accelerate its growth and technology roadmap. The transaction involved the sale of 12,100 shares of Preferred Stock at $1,000 per share, featuring an 8% dividend payable in common stock and an initial conversion price of $1.00.
• 3mo ago AI analysis › Press Release ● Major
Marpai Inc. Announces Debt Restructuring Agreements with JGB Capital and AXA, Reducing Debt Service by $26.4 Million Through 2027 and Enhances Near term Liquidity
Marpai Inc. has entered into debt restructuring agreements with its principal lenders, JGB Capital and AXA S.A., extending maturities to April 2028 and December 2029, respectively. These agreements are projected to reduce debt service expenditures by $26.4 million through 2027, providing the company with enhanced near-term liquidity and financial flexibility.
• 3mo ago AI analysis › Press Release ● Major
Marpai Inc. Announces Unprecedented Growth with 192,000 New Estimated Member Lives Across TPA and MarpaiRx PBM Platforms; Expects to Achieve Positive Cash Flow and EBITDA Beginning August 2026
Marpai Inc. announced a historic expansion of its business book, estimating 192,000 new member lives across its TPA and MarpaiRx PBM platforms. These new commitments represent a nearly six-fold increase in current member lives, with 37,500 TPA lives and 50,000 PBM lives explicitly detailed in the rollout schedule.
• 5mo ago AI analysis › Press Release
MARPAI REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS
Marpai reported Q1 2026 revenue of $4.4 million, down 18% year-over-year, with an operating loss of $2.5 million and a net loss of $3.2 million ($0.13 per share). The company attributes the results to deliberate investments in cloud migration and temporary staffing, noting that total costs and expenses fell 10% YoY to $6.9 million. Management reaffirmed its target to achieve run-rate profitability in the second half of 2026, supported by a completed cloud migration and a new debt amendment with JGB Management that reduces near-term cash outlays.
• 6mo ago AI analysis › Press Release ● Major
Marpai, Inc. Announces Significant New Business Wins across TPA and MarpaiRx; Solidifies Forecast for Profitability
prnewswire.com • 6mo ago